The results demonstrated that OCT4 activated the vascular endothelial growth factor (VEGF)-C/VEGF receptor 3 (VEGFR-3) signaling pathway, thus inducing EMT in ECC cells and promoting the lymphatic metastasis of cancer cells. Here, FLT4 is linked to cancer.